Innovent Biologics, Inc.
Last quote: (Paris time)
Source: Yahoo FinanceDelayed quotesOutdated data
Synthèse : Innovent Biologics, Inc.
Innovent Biologics, Inc. (1801.HK) est cotée sur HKSE (Asia), dans le secteur Health. Son cours est exprimé en HKD. TimeLinq suit 120 autres valeurs du secteur Health, avec lesquelles cette fiche permet de la comparer.
Sa capitalisation boursière atteint 155.29B HKD. Son PER sur les 12 derniers mois est de 117.2. Sa marge nette ressort à 7.8%. It does not pay a dividend based on available data.
Sur un an, le cours a varié de +3.4%, avec une volatilité annuelle de 46%. Le cours se situe au-dessus de sa moyenne mobile à 200 jours (+1.4%).
Indications calculated automatically from public market data; they do not constitute investment advice.
Price change
Innovent Biologics, Inc. : de 94.10 HKD à 89.05 HKD over 1 month, soit une variation de −5.37%.
Source: Yahoo FinanceDelayed quotes, Paris timeOutdated data
Key figures
- Previous close
- HK$87.75
- Day's range
- HK$88.00 – HK$92.45
- Volume (shares)
- 9,711,337
- Listing venue
- HKSE
- 52-Week Range
- HK$69.55HK$112.70
Source: Yahoo FinanceOutdated data
In brief
The key figures, explained simply.
- 1-year performance
- +3.4%Change in share price over the past 12 months.
- Market capitalization
- 155.29B HKDTotal market value of the company.
- P/E (12M)
- 117.2How many years of current earnings the share price represents.
- Net margin
- 7.8%Out of every 100 in sales, what remains as profit.
- Volatility (1 year)
- 46%Typical magnitude of share price moves over one year.
- Dividend yield
- No dividendAnnual dividend relative to the share price.
Source: Yahoo Finance (données fondamentales)Published accounts, indicative data
Company profile
- Sector
- Health
- Listing venue
- HKSE
- Region
- Asia
- Quote currency
- HKD
Other companies in the Health sector
Click a company to open its profile, or compare it directly.
| Company | Price | Change | Market capitalization | P/E | Compare |
|---|---|---|---|---|---|
| Alibaba Health0241.HK | HK$3.01 | +1.52% | 48.61B HKD | 23.1 | Compare |
| CSPC Pharmaceutical Group1093.HK | HK$8.88 | +0.17% | 101.28B HKD | 12.2 | Compare |
| Hansoh Pharmaceutical Group3692.HK | HK$31.74 | +1.15% | 192.43B HKD | 25.8 | Compare |
| JD Health6618.HK | HK$38.56 | +2.17% | 122.99B HKD | 17.8 | Compare |
| Apollo HospitalsAPOLLOHOSP.NS | ₹7,890.00 | +0.01% | 1.13T INR | 54.3 | Compare |
| CiplaCIPLA.NS | ₹1,325.10 | −0.22% | 1.07T INR | 31.8 | Compare |
| Dr. Reddy's LaboratoriesDRREDDY.NS | ₹1,233.00 | +1.17% | 1.03T INR | 31.0 | Compare |
| Max HealthcareMAXHEALTH.NS | ₹846.00 | −1.40% | 823.42B INR | 56.7 | Compare |
| Sun PharmaSUNPHARMA.NS | ₹1,758.80 | −0.29% | 4.22T INR | 34.9 | Compare |
| Jiangsu Hengrui Pharmaceuticals600276.SS | CN¥46.63 | +0.06% | 309.49B CNY | 40.2 | Compare |
Source: Yahoo FinanceDelayed quotes